Edit search
Imiquimod 5%25 cream for the treatment of actinic keratosis%…
Imiquimod 5%25 cream for the treatment of actinic keratosis%3A results from a phase III%2C randomized%2C double-blind%2C vehicle-controlled%2C clinical trial with histology.
Imiquimod 5%25 cream for the treatment of actinic keratosis%3A results from a phase III%2C randomized%2C double-blind%2C vehicle-controlled%2C clinical trial with histology.
Article, Chapter
Authors: R.M. Szeimies
Publication: Journal of the American Academy of Dermatology, Volume:51, Issue:4, Page(s):547-555
Published: Mosby, 2004
ISSN: 0190-9622
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item